A number of cancer vaccines are now entering the final stage of clinical development. Are vaccines finally on their way to enjoying mainstream success in the oncology arena?
Cancer vaccines edge towards success
Richard Harrop and Stuart Naylor
Related Articles
CancerWorld Plus
Bringing you extra in 2018
Drug Watch
PHARE: shining a light for academic research in Europe
Drug Watch
Leave a Reply